TWI473997B - Electrosensing antibody-probe detection and measurement sensor having conductivity promotion molecules - Google Patents

Electrosensing antibody-probe detection and measurement sensor having conductivity promotion molecules Download PDF

Info

Publication number
TWI473997B
TWI473997B TW99100058A TW99100058A TWI473997B TW I473997 B TWI473997 B TW I473997B TW 99100058 A TW99100058 A TW 99100058A TW 99100058 A TW99100058 A TW 99100058A TW I473997 B TWI473997 B TW I473997B
Authority
TW
Taiwan
Prior art keywords
antibody
electrodes
wafer
sensing
antigen
Prior art date
Application number
TW99100058A
Other languages
Chinese (zh)
Other versions
TW201142288A (en
Inventor
Shiming Lin
Adam Shih Yuan Lee
Bor Ching Sheu
Chih Chen Lin
Panchien Lin
Original Assignee
Shiming Lin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiming Lin filed Critical Shiming Lin
Priority to TW99100058A priority Critical patent/TWI473997B/en
Publication of TW201142288A publication Critical patent/TW201142288A/en
Application granted granted Critical
Publication of TWI473997B publication Critical patent/TWI473997B/en

Links

Landscapes

  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)

Description

具有導電性誘昇分子之電性感測抗體探針偵檢及量測感測器Electro-sensing antibody probe detection and measurement sensor with conductive trapping molecules

本發明大致係有關於使用抗體(antibody)作為探針(probe)而利用電性感測(electrosesning)所進行之偵檢(detection)及量測(measurement)。特定而言,本發明係有關於可用於電性感測抗體探針偵檢及量測之感測器及其相關方法。 The present invention is generally directed to detection and measurement using electrosensing using an antibody as a probe. In particular, the present invention relates to sensors and related methods that can be used for electro-detection antibody probe detection and measurement.

在醫學及其相關應用領域中,使用生物晶片(biochip)來對檢測樣本中的目標物質(target substrate)進行偵檢已屬習知。在諸如精確度及成本等因素考量之下,生物晶片感測器(biochip sensor,或,biosensor)已被應用於特定目標物質之偵檢。若技術可行且成本可以接受,對於任何可以想像到的用途而言,在檢測目標物質之出現與否之外,若能更進一步進行定量量測,則生物晶片感測器顯然是更有其用處。例如,在生物醫療(biomedical)應用之中,若能以,例如,由1至10,1至100,甚或更高的解析度,並且維持精確度,而量測指出目標物質出現於樣本中之程度尺度,對於其原定感測應用目的而言,顯然極具資訊性。 In medical and related fields of application, it is known to use biochips to detect target substrates in a test sample. Biochip sensors (or biosensors) have been applied to the detection of specific target substances under considerations such as accuracy and cost. If the technology is feasible and cost-effective, biochip sensors are clearly more useful for any imaginable use, in addition to detecting the presence or absence of target substances, if further quantitative measurements are made. . For example, in biomedical applications, if, for example, from 1 to 10, 1 to 100, or even higher resolution, and maintaining accuracy, the measurement indicates that the target substance is present in the sample. The degree scale is obviously very informative for the purpose of its original sensing application.

以光學感測(optical sensing)技術為基礎的生物晶片,是為今日全球生物感測技術所常見者。此類晶片所依賴的是,需要利用龐大笨重且價格昂貴的精密光學儀器,進行光學感測才得以讀取晶片上的檢測反應結果。為避開此些問題,利用電性感測原理的生物晶片顯然是微小化與低成本的合理作法。在電性感測晶片的技術之中,當晶片置身於檢測樣本中之後,其檢查(或者,感測)是電學性的檢查。由待檢測樣本上所感測到的可以是阻抗值(impedance),電容值(capacitance),電阻值(resistance),導電度(conductance),電流值(current),或任何其他有用的任何電性參數。 Biochips based on optical sensing technology are common to today's global biosensing technology. Such wafers rely on the need for optical sensing to capture the results of the detection reaction on the wafer using a large, bulky and expensive precision optical instrument. In order to avoid these problems, the biochip using the principle of electro-pressure is obviously a reasonable method of miniaturization and low cost. Among the techniques of electro-sensing wafers, after the wafer is placed in the test sample, its inspection (or sensing) is an electrical inspection. Sensed by the sample to be detected may be impedance, capacitance, resistance, conductance, current, or any other useful electrical parameter. .

然而,直至目前為止,電性生物感測的技術有其限制,此係因絕大多數液體生物檢測樣本,其本質皆未具電傳導性之故。圖3A及3B說明習知之電性感測技術,如何不適於利用抗體探針進行抗原(antigen)檢測的情形。例如,圖3A以示意圖說明一種習知技術感測晶片300所使用的是,例如固定在晶片正極312及負極314兩電極表面上的抗體分子免疫球蛋白G(immunoglobulin G)322,其中之電極可為,例如,金(Au),銀(Ag),銅(Cu)或鎳(Ni)等之金屬薄膜。若要擁有實際用途,此系統必須要能夠容許量測得到圖中大致以參考標號305所標示之環境,即感測晶片300的兩電極之間,其中電流之變化量。 However, until now, the technology of electrical biosensing has its limitations, which is due to the fact that most liquid bioassay samples are not electrically conductive. 3A and 3B illustrate how conventional electro-sensing techniques are not suitable for antigen detection using antibody probes. For example, FIG. 3A schematically illustrates a conventional technique for sensing a wafer 300 using, for example, an antibody molecule immunoglobulin G (322) immobilized on the surface of both the positive electrode 312 and the negative electrode 314 of the wafer, wherein the electrode can be For example, a metal film of gold (Au), silver (Ag), copper (Cu) or nickel (Ni). To have a practical use, the system must be capable of permitting the measurement of the environment generally indicated by reference numeral 305 in the figure, i.e., sensing the amount of change in current between the two electrodes of wafer 300.

不過,在待檢測樣本導入之後,當其中的抗原分子332(其大部份本質上皆為非導體或不良導體)與固定(immobilized)在電極表面上的抗體分子322相互作用(interaction)之後,此感測系統之電極之間的電傳導性,實際上仍是極為不良,如圖3B之示意圖所示。因此,習知技藝之電性感測晶片技術,目前為止,僅適用於以酵素(enzyme)或催化劑(catalyst)作為探針,以進行氧化還原作用產生電流電壓變化的生物晶片,其應用用途因此極度受限。 However, after the introduction of the sample to be tested, after the antigen molecule 332 therein (which is mostly a non-conductor or a poor conductor in nature) interacts with the antibody molecule 322 immobilized on the surface of the electrode, The electrical conductivity between the electrodes of this sensing system is still extremely poor, as shown in the schematic of Figure 3B. Therefore, the electro-sensing wafer technology of the prior art is only applicable to a biochip which uses an enzyme or a catalyst as a probe to perform a redox reaction to generate a current-voltage change, and its application is extremely extreme. Limited.

因此,本發明之目的係在於提供一種可利用電性感測抗體晶片進行偵檢及量測之感測器以供檢測各種目標物質之存在。 Accordingly, it is an object of the present invention to provide a sensor for detecting and measuring an electrosensing antibody wafer for detecting the presence of various target substances.

本發明之目的亦在於提供一種電性感測抗體探針供偵檢及量測不同程度表現量以供檢測各種目標物質之存在及各種目標物質之多寡。 The object of the present invention is also to provide an electrosensing antibody probe for detecting and measuring different degrees of expression for detecting the presence of various target substances and the amount of various target substances.

本發明之另一目的為提供一種簡單,小型,且低成本之電性感測抗體探針偵檢及量測感測器,以取代大型,高精準度以及昂貴的硬體設備。 Another object of the present invention is to provide a simple, small, and low-cost electro-sensing antibody probe detection and measurement sensor to replace large, high-precision, and expensive hardware devices.

本發明之又一目的在於提供一電性感測抗體探針偵檢及量測感測器,其可用來檢測各種不同的目標物質,並可廣泛應用在生物醫學之外的領 域,例如環境控制和工業界。 Another object of the present invention is to provide an electrosensing antibody probe detection and measurement sensor which can be used for detecting various target substances and can be widely applied to biomedical products. Domains such as environmental control and industry.

為達成上述及其他目的本發明提供一種可供電性感測抗體探針偵檢及量測之硫醇基寡噻吩(mercapto-oligothiophene)導電性誘昇化合物。電性感測之感測器包含有二電極以及固定於至少一電極表面上的一層抗體。導電性誘昇分子被繫接於固定有該抗體之該些電極上方及/或分佈於其間以增進兩電極間之電性傳導特性。就一特定層面而言,本發明之電性感測晶片及其相關方法中之抗體探針分子可以說是「穿上了一件具電傳導性的緊身衣」,此使得系統中的電傳導性實質上變得被「放大」到應用今日之儀器足以進行精確感測的程度。電性感測晶片的諸如電阻值等的可量測電性參數,如此不但變得可以偵檢並且得以判讀大小,其因此而變成可供進行解讀的有意義參數。 To achieve the above and other objects, the present invention provides a mercapto-oligothiophene conductive eliciting compound which is capable of detecting and measuring a probe capable of supplying a test antibody. The electrosensing sensor comprises a second electrode and a layer of antibody immobilized on the surface of at least one of the electrodes. A conductively-exposed molecule is attached to and/or distributed between the electrodes to which the antibody is immobilized to enhance electrical conductivity between the electrodes. In a particular aspect, the antibody probe molecule of the electrosensitized wafer of the present invention and related methods can be said to be "wearing a tight layer with electrical conductivity", which makes electrical conductivity in the system. Essentially becomes "amplified" to the extent that the instrument used today is sufficient for accurate sensing. The measurable electrical parameters of the electrical sensing wafer, such as resistance values, thus become not only detectable but also readable, which thus becomes a meaningful parameter for interpretation.

本發明提供一種可供電性感測一檢測樣本中之抗體之一感測器,其包含電性不連接且實質互相分離之二電極;固定於該些電極其中至少一電極之表面上的一層抗體,該抗體相對於該抗原具有具備專一性之結合反應性;與共價鍵結於該些抗體上以增進該兩電極間之導電性質之導電性誘昇分子。當出現於與一緩衝液混合之該檢測樣本中之該抗原與該固定有抗體之電極相接觸時,該抗體捕捉該抗原,並因而改變該兩電極之間的電性傳導特性,其中代表該改變的量提供了對該抗原進行電性感測的一個定性及定量指標。 The present invention provides a sensor for powering a sensory test sample, comprising two electrodes electrically disconnected and substantially separated from each other; and a layer of antibody immobilized on a surface of at least one of the electrodes, The antibody has specific binding reactivity with respect to the antigen; and a conductive attracting molecule covalently bonded to the antibodies to enhance the conductive properties between the electrodes. When the antigen present in the test sample mixed with a buffer is contacted with the antibody-immobilized electrode, the antibody captures the antigen and thereby changes the electrical conduction characteristics between the electrodes, wherein The amount of change provides a qualitative and quantitative indicator of electrosensitivity of the antigen.

本發明利用提昇感測晶片系統(晶片環境以及與其發生反應之抗體分子本身)之電傳導性,而得以做到有實質用途之電感測。特定而言,本發明之感測晶片及其相關方法中之抗體探針分子可以說是「穿上了一件具有電傳導性的緊身衣」,此使得系統中的電傳導性實質上變得被「放大」到應用今日之儀器足以進行精確感測的程度。感測晶片的諸如電阻值等的可量測電 性參數,如此不但變得可以偵檢並且得以判讀大小,其因此而變成可供進行解讀的有意義參數。 The present invention utilizes the electrical conductivity of the sensing wafer system (the wafer environment and the antibody molecules itself that react with it) to achieve a practical use of the inductance measurement. In particular, the antibody probe molecule of the sensing wafer of the present invention and related methods can be said to be "wearing a tight-fitting electric conductive body", which makes the electrical conductivity in the system substantially become The instrument that is "zoomed in" to the application of today is sufficient for accurate sensing. Sensitive measurement of a wafer such as a resistance value Sexual parameters, so that not only become detectable and can be interpreted, it becomes a meaningful parameter for interpretation.

依據本發明,被固定在感測晶片上作為檢測探針的抗體,實質上是由其非導電體本質被轉變成為半導電性甚至是良好導電性的物質。此可容許被檢測樣本液體中目標物質(在其與感測晶片上的抗體接觸並發生反應之後)的電性阻抗變化數值,不但變成可以被儀器檢測出來,更能以足夠的精確度加以量測判別。量測讀取所得數值因此便可應用於原定目標物質檢測用途中之解讀。 According to the present invention, an antibody immobilized on a sensing wafer as a detecting probe is substantially converted into a semiconducting or even a good electrical conductivity by its non-conducting nature. This allows the value of the electrical impedance change of the target substance in the sample liquid to be detected (after it contacts and reacts with the antibody on the sensing wafer), which can be detected not only by the instrument but also with sufficient accuracy. Test discrimination. The measured readings can therefore be applied to the interpretation of the intended target substance detection.

事實上,如同習於本技藝者所可理解,除了阻抗值以外,諸如系統的電容值等其他電氣參數,亦皆由於本發明將整個系統的電傳導性加以提昇,而全皆變得可加以量測。此外,除了解讀作為電阻值的倒數的嚴謹定義之外,「電導度」一詞在本發明之範疇內亦可更為廣泛地被解讀為其系統中的電性傳導狀態。因此,「導電性誘昇」一詞在此應被解讀為「電性傳導狀態之增進」。 In fact, as can be understood by those skilled in the art, in addition to the impedance value, other electrical parameters such as the capacitance value of the system are also improved by the present invention by improving the electrical conductivity of the entire system. Measure. Moreover, in addition to interpreting the rigorous definition of the reciprocal of the resistance value, the term "conductivity" is more broadly interpreted within the scope of the invention as the electrically conductive state in its system. Therefore, the term "conductivity induced" should be interpreted here as "the enhancement of the electrical conduction state".

因此,本發明之感測器及方法便能夠建立一種電性傳導之環境,其可以容許因為被捕捉到的目標物質之出現於環境中,所導致之電傳導性的變動,變成不但可以被偵測到,並且可加以量測判讀。由於本發明之感測器及方法,實質上乃是將整個檢測樣本系統的電特性偵檢範圍加以放大,因此其中電性質的任何變動,不論是阻抗,電流或電容,不論是以直流(DC)或任何選定頻率的交流(AC)加以量測,便皆很容易地可偵測到,並可精確加以量化。其中之變化量因此即可成為被檢測樣本中目標物質存在量的一種量化指標。 Therefore, the sensor and method of the present invention can establish an environment of electrical conduction, which can allow the change of electrical conductivity caused by the appearance of the captured target substance in the environment, and can be detected not only Measured and can be measured and interpreted. Since the sensor and method of the present invention substantially amplifies the electrical characteristic detection range of the entire test sample system, any variation in electrical properties, whether impedance, current or capacitance, whether it is DC or DC ) or any selected frequency of alternating current (AC) measurements are easily detectable and accurately quantified. The amount of change can thus be a quantitative indicator of the amount of target substance present in the sample being tested.

圖1顯示本發明一基本電性感測系統之架構。建構在一片基材110上的感測晶片100具有固定在其正電極112及負電極114表面上的整層的抗體探針120,其中的電極可為,例如,Au,Ag,Cu或Ni等之金屬薄膜。電極112及114係作為固定為特定抗原所選定之抗體探針的實質基底。 Figure 1 shows the architecture of a basic electro-sensing system of the present invention. The sensing wafer 100 constructed on a substrate 110 has an entire layer of antibody probes 120 fixed on the surfaces of its positive electrode 112 and negative electrode 114, wherein the electrodes may be, for example, Au, Ag, Cu or Ni, etc. Metal film. Electrodes 112 and 114 serve as substantial substrates for antibody probes selected for immobilization to a particular antigen.

以電性感測晶片100為基礎的本發明新穎電性感測技術之一種實施例系統,可與一檢測電路與流體系統結合而提供一感測腔體(chamber)102。在此腔體之中,檢測樣本與晶片發生接觸,以容許懸浮在液態樣本中的目標抗原分子134得以變成被抗體探針120所捕捉住的抗原132。 An embodiment of the novel electro-sensing technique of the present invention based on the electro-sensing wafer 100 can be combined with a detection circuit and a fluid system to provide a sensing chamber 102. Within this cavity, the test sample is brought into contact with the wafer to allow the target antigen molecule 134 suspended in the liquid sample to become the antigen 132 captured by the antibody probe 120.

如同以下所將詳細說明者,圖1中之系統容許對檢測樣本中的目標抗原濃度進行精確量測。此係利用在感測晶片的電極之間施加一電壓,並透過一電流量測儀器而進行量測的,如同圖中所顯示者。 As will be explained in more detail below, the system of Figure 1 allows accurate measurement of the concentration of target antigen in the test sample. This is measured by applying a voltage between the electrodes of the sensing wafer and passing through a current measuring instrument, as shown in the figure.

圖2A及2B顯示依據本發明一較佳實施例電性感測晶片之兩種可能組構(configuration)。圖2A之感測晶片200A係採用典型平片形晶片形態,其感測電極212A及214A係在其基材210A上併排安置。此種平片形之晶片組構,係依賴其對應晶片讀取處理裝置之配合,以形成其感測可以進行的一個樣本腔體。 2A and 2B show two possible configurations of an electro-sensing wafer in accordance with a preferred embodiment of the present invention. The sensing wafer 200A of FIG. 2A is in the form of a typical flat wafer, with sensing electrodes 212A and 214A disposed side by side on its substrate 210A. Such a flat sheet-shaped wafer structure relies on the cooperation of its corresponding wafer reading processing device to form a sample cavity in which sensing can be performed.

相較之下,圖2B之電性感測晶片200B則具有管狀之組構(tubular configuration),其兩感測電極212B及214B係被設置在其管狀「基材」210B內部表面的互相面對位置上。利用此種管狀構形,只要在晶片被插入其對應之處理讀取機器時將其兩端加以封閉,感測晶片200B便很容易地獲得一個樣本腔體202B。 In contrast, the electro-sensing wafer 200B of FIG. 2B has a tubular configuration in which the two sensing electrodes 212B and 214B are disposed facing each other on the inner surface of the tubular "substrate" 210B. on. With such a tubular configuration, as long as the wafer is inserted into its corresponding processing reading machine to close its ends, the sensing wafer 200B can easily obtain a sample cavity 202B.

圖4A-4C分別顯示依據本發明感測晶片之一較佳實施例其製備及其對一様本進行感測之情形。注意到圖中所顯示電極,抗體,抗原及導電性誘昇分子等並未依正確尺度比例繪示。為利於本發明之解釋說明,圖中所顯示者有部份係以誇大比例繪示。 4A-4C respectively illustrate the preparation of a preferred embodiment of a sensing wafer in accordance with the present invention and the sensing of a sample thereof. It is noted that the electrodes, antibodies, antigens, and conductive attracting molecules shown in the figure are not shown in the correct scale. In order to facilitate the explanation of the present invention, some of the figures shown in the drawings are shown in an exaggerated proportion.

圖4A顯示本發明一感測晶片之基本系統,在一個具有電傳導性的環境之中,其整體導電性質,係利用導電性誘昇分子而得以提昇。在一較佳實施例中,薄膜形態的Au被用來在感測晶片400的基材410上形成基本的正及負電極412與414。諸如Ag、Cu及Ni等的金屬,於本發明中亦得以被利用來製作電極。依用途之不同,適當的合金,例如,銦錫氧化物(indium tin oxide,ITO),亦可使用。 Figure 4A shows the basic system of a sensing wafer of the present invention in which the overall conductive properties of an electrically conductive environment are enhanced by the use of conductive attracting molecules. In a preferred embodiment, the film-formed Au is used to form substantially positive and negative electrodes 412 and 414 on the substrate 410 of the sensing wafer 400. Metals such as Ag, Cu, and Ni are also utilized in the present invention to fabricate electrodes. Suitable alloys, for example, indium tin, depending on the application Oxide, ITO), can also be used.

具電傳導性之分子442被鍵結在電極上,此係如圖中所繪示的,其係被固定在電極表面上。依據本發明,此些分子因而形成了固定在電極表面的導電性誘昇分子。當本發明之晶片被使用時,此可令本發明之基本感測系統,得以提供一個增強的電性傳導環境,而這是由於該些導電性誘昇分子修飾了感測晶片的表面性質,其結果使得裸感測晶片系統的電傳導性得以提昇。亦即,在抗體探針分子出現在晶片系統中之後,正電極與負電極之間的導電性因此大為增進。由於圖中以405A所標示的,電極412及414之間的大為改善的電性傳導環境之故,此時系統便可以在感測晶片400的電極之間感測抗原存在前後的電流變化。 The electrically conductive molecule 442 is bonded to the electrode, as shown in the figure, which is attached to the electrode surface. According to the invention, such molecules thus form conductive attracting molecules immobilized on the surface of the electrode. When the wafer of the present invention is used, this allows the basic sensing system of the present invention to provide an enhanced electrical conduction environment, since the conductive attracting molecules modify the surface properties of the sensing wafer, As a result, the electrical conductivity of the bare sensing wafer system is improved. That is, after the antibody probe molecules are present in the wafer system, the conductivity between the positive electrode and the negative electrode is greatly enhanced. Because of the greatly improved electrical conduction environment between electrodes 412 and 414 as indicated by 405A in the figure, the system can sense the change in current before and after the presence of the antigen between the electrodes of sense wafer 400.

適於用作導電性誘昇的物質包括,但不限於,寡噻吩-矽烷(oligothiophene-silane),寡噻吩-硫醇(oligothiophene-thiol),1-苯基寡噻吩((1-phenyl)-oligothiophene),2-苯基寡噻吩((2-phenyl)-oligothiophene),支鏈寡噻吩(side-arm oligothiophene),寡苯基噻吩寡聚物(oligophenyl oligothiophene),以及其衍生物等。 Substances suitable for use as conductive attractants include, but are not limited to, oligothiophene-silane, oligothiophene-thiol, 1-phenyl oligothiophene ((1-phenyl)- Oligothiophene), 2-phenyl-oligothiophene, side-arm oligothiophene, oligophenyl oligothiophene, and derivatives thereof.

在圖4B中,針對特定目標抗原之探針用途的抗體422,被加至感測晶片400的導電性誘昇分子層上,並與其共價鍵鍵結。因為具有此層固定化抗體,在此一階段(即當目標抗原尚未出現時),感測晶片的導電值於此已具有電導性的環境405B中,會有些減降,但仍是在易於使用儀器進行量測的範圍之中。 In FIG. 4B, antibody 422 for probe use of a particular target antigen is applied to the layer of conductively induced molecules of the sensing wafer 400 and is covalently bonded thereto. Because of this layer of immobilized antibody, at this stage (ie, when the target antigen has not yet appeared), the conductivity of the sensing wafer is somewhat reduced in this already electrically conductive environment 405B, but is still easy to use. The instrument is within the range of measurement.

當抗體422出現之後,圖4B中的晶片400便形成了備妥可針對其特定目標抗原分子進行電性感測應用的一只電抗體感測器(electric antibody sensor)。就任何預先設定的感測用途而言,其對應之特定非導電性抗體分子需要先被固定在晶片上。例如,免疫球蛋白G(immunoglobulin G)分子可以被使用作為檢測諸如S100,甲型胎兒蛋白(alpha-fetoprotein),以及心肌鈣蛋白I(tropolin I)等的抗體探針。系統的整體電傳導性會有所減降, 其程度反映了探針之出現在系統中的事實。電導度的此一變化值變成了檢測時之量測參考基準值。 When antibody 422 is present, wafer 400 in Figure 4B forms an electric antibody sensor that is ready for electro-sensing applications for its particular target antigen molecule. For any predetermined sensing application, the corresponding specific non-conductive antibody molecule needs to be first immobilized on the wafer. For example, an immunoglobulin G molecule can be used as an antibody probe for detecting, for example, S100, alpha-fetoprotein, and tropolin I. The overall electrical conductivity of the system will be reduced, The extent reflects the fact that the probe is present in the system. This change in electrical conductivity becomes the reference reference value at the time of detection.

圖4C顯示利用將目標抗原曝露給固定在晶片上的探針抗體,而進行電性感測的情況。圖4B中已備妥探針可供進行感測的晶片400被曝露在一檢測樣本之下。由於針對特定目標可進行檢測的探針抗體422已被鍵結固定在晶片上,存在於樣本之中的目標,亦即,抗原432,便被抗體所捕捉,或者是說,與抗體產生相互作用(interaction)反應。 Fig. 4C shows a case where electrosensing is performed by exposing a target antigen to a probe antibody immobilized on a wafer. The wafer 400 in Figure 4B in which the probe has been prepared for sensing is exposed under a test sample. Since the probe antibody 422 that can be detected for a specific target has been immobilized on the wafer, the target present in the sample, that is, the antigen 432, is captured by the antibody or, in other words, interacts with the antibody. (interaction) reaction.

隨著被捕捉住的抗原分子432之出現在系統之中,整個電性傳導環境405C的整體電導度便隨著進一步變動(即,相較於圖4B),而其電性阻抗量測讀數之變動(即,作為電極間之電流而被量測者),便成為系統中所出現抗原數量之程度的一個指標。 As the captured antigenic molecules 432 appear in the system, the overall conductivity of the entire electrically conductive environment 405C changes further (i.e., compared to Figure 4B), and its electrical impedance measurement reads. The change (i.e., measured as the current between the electrodes) becomes an indicator of the extent of the amount of antigen present in the system.

依據本發明所進行之電性感測,當含有非導電性目標抗原的樣本,被導入圖4C之感測晶片所提供的流體偵檢量測環境內時,系統的整體電傳導性便會隨之變動減降。此種減降係以量測所得電流值的對應減降加以反映。其變動程度係與代表被晶片所捕捉住目標抗原的數量成比例。不過,應予注意的是,在某些情況下,檢測樣本內某些抗原之與抗體探針結合(binding)後,相較於該些抗原尚未出現在系統中之前,反有可能會導致電導度的增升。 According to the electro-sensing test performed by the present invention, when a sample containing a non-conductive target antigen is introduced into the fluid detection measurement environment provided by the sensing wafer of FIG. 4C, the overall electrical conductivity of the system is followed. The change is reduced. This reduction is reflected by the corresponding decrease in the measured current value. The degree of variation is proportional to the number of antigens that are captured by the wafer. However, it should be noted that in some cases, after binding of certain antigens in the test sample to the antibody probe, it may lead to conductance compared to the fact that the antigens have not appeared in the system before they appear in the system. The increase in degrees.

圖5A-5C分別顯示依據本發明感測晶片之另一較佳實施例,其製備及其對一様本進行感測之情形。圖5A-5C所描述之實例與圖4A-4C中所顯示者,除了其感測晶片的物理構造,係採用互相面對的電極設置定位以外,兩者實質上是相同的。依本發明之推論(但本發明不應受限於此推論),此種電極對置之組構,應可能因其相對於圖4A-4C之平片形組構之較佳導電性質,而得以容許產生較佳的感測性能。 Figures 5A-5C respectively illustrate another preferred embodiment of sensing a wafer in accordance with the present invention, which is prepared and sensed for a sample. The examples depicted in Figures 5A-5C and those shown in Figures 4A-4C, except that they sense the physical configuration of the wafer, are positioned substantially identically with the electrodes facing each other. In accordance with the inference of the present invention (but the invention should not be limited to this inference), the arrangement of such electrodes may be due to their preferred conductive properties relative to the planar configuration of Figures 4A-4C. It is allowed to produce better sensing performance.

圖6之示意圖解釋本發明電性感測晶片及方法何以具有其實質用途。圖中之曲線顯示一檢測樣本之導電性質,相較於樣本中所出現之抗原濃度 的相對關係。 Figure 6 is a schematic diagram showing the practical use of the electro-sensing wafer and method of the present invention. The curve in the figure shows the conductivity of a test sample compared to the antigen concentration present in the sample. The relative relationship.

圖6中垂直軸,即電傳導性質軸,上的符號A,B,C,D,D’及D”,分別係為感測晶片在其製備過程中各個不同階段的電傳導性: The vertical axis in Figure 6, i.e., the axis of electrical conduction properties, on the symbols A, B, C, D, D' and D", respectively, is the electrical conductivity of the sensing wafer at various stages during its preparation:

A:基材 A: substrate

B:電極 B: electrode

C:電導度誘昇 C: Conductivity induced

D,D’,D”:抗體探針加入 D, D', D": antibody probe addition

為了要對樣本內所存在的目標抗原,進行一個寬廣範圍濃度的量測,習知技藝係在圖中的小電流量測讀取範圍(BD’或BD”,依所加入之探針會稍微減降或增升其整體電傳導性而定)內試圖量測樣本的導電性讀數。其電流值的讀數範圍小到無法有實際用途,不但難以判別目標物質有否存在,更無庸說能夠以可接受的讀取解析度得出樣本內的抗原濃度曲線,E’或E”。 In order to perform a wide range of concentration measurement on the target antigen present in the sample, the conventional technique is in the small current measurement reading range (BD' or BD" in the figure, depending on the probe to be added. In the case of reducing or increasing the overall electrical conductivity, it is attempted to measure the conductivity reading of the sample. The reading range of the current value is too small to be practical, and it is difficult to distinguish whether the target substance exists or not. Acceptable read resolution yields an antigen concentration curve within the sample, E' or E".

相較之下,若依本發明使用導電性誘昇分子,目標物質的檢測範圍(BD),就某一層面之意義而言,乃是被實質放大了,其因而可以容許以良好的解析度,換言之即較佳的精準度,而讀取判定目標濃度。這是由於,如圖6中的特性曲線E所清楚顯現的,不論液體樣本環境中目標物質濃度與在其中之對應測得電流之間是為線性或非線性關係,在寬廣的量測對應範圍內所進行的目標偵檢,當然可使儀器讀數的解讀遠較為容易之故。 In contrast, if a conductive attracting molecule is used according to the present invention, the detection range (BD) of the target substance is substantially enlarged in the sense of a certain level, which can thus allow a good resolution. In other words, the accuracy is better, and the target concentration is read. This is because, as clearly shown by the characteristic curve E in Fig. 6, regardless of whether the concentration of the target substance in the liquid sample environment is linear or nonlinear between the corresponding measured currents, the broad measurement range is corresponding. The target detection carried out inside can of course make the interpretation of the instrument readings easier.

圖7說明依據本發明一實施例感測晶片,其上有以導電性誘昇分子共價鍵結所固定之抗體,此些導電性誘昇分子可提昇整個檢測系統中的電傳導性。在一較佳實施例中,以圖7的感測晶片700為例,抗體分子722在固定在電極712和714表面之前,先使用導電性誘昇分子742調整其共價鍵結。不過,如同習於本技藝者所可以理解的,在另一實施例中,抗體分子722可以先固定在電極712和714表面,隨後再使用導電性誘昇分子742加以調整修飾。 Figure 7 illustrates a sensing wafer having antibodies immobilized by covalent bonding of conductively-exposed molecules, which enhance electrical conductivity throughout the detection system, in accordance with an embodiment of the present invention. In a preferred embodiment, taking the sensing wafer 700 of FIG. 7 as an example, the antibody molecules 722 are first adjusted for covalent bonding using conductive deriving molecules 742 prior to immobilization on the surfaces of electrodes 712 and 714. However, as will be appreciated by those skilled in the art, in another embodiment, antibody molecules 722 can be immobilized on the surfaces of electrodes 712 and 714, and then modified using conductive attracting molecules 742.

與圖4之系統中的導電性誘昇分子442被用來當作固定抗體422和感測晶片電極412/414的連結劑的情形不同的是,圖7中有多於一個以上的導電性誘昇分子742和每一個抗體分子722結合。此一安排適用於該些可以直接與電極分子連結而被固定在電極上的抗體。 Unlike the case where the conductive attracting molecules 442 in the system of FIG. 4 are used as the bonding agent for the immobilized antibody 422 and the sensing wafer electrode 412/414, there are more than one conductive attractant in FIG. Ascending molecule 742 binds to each antibody molecule 722. This arrangement is applicable to antibodies which can be directly attached to the electrodes by being attached to the electrodes.

相較之下,在另一較佳實施例中,對圖8中的感測晶片800之系統而言,導電性誘昇分子842也被用來將抗體822連結在電極812/814上。如上所述,這些導電性誘昇分子在系統中扮演著雙重角色。導電性誘昇分子不但可以促進系統的電導度,並且可以連結抗體分子和電極。和圖4的系統相較之下,導電性誘昇分子842被運用在抗體上時又可以更進一步地提升系統的電導度。 In contrast, in another preferred embodiment, for the system of sensing wafer 800 of FIG. 8, conductive attracting molecules 842 are also used to bond antibody 822 to electrodes 812/814. As noted above, these conductively induced molecules play a dual role in the system. Conductively induced molecules not only promote the electrical conductivity of the system, but also bind the antibody molecules and electrodes. In contrast to the system of Figure 4, the conductivity-exposed molecules 842 can be used to further enhance the electrical conductivity of the system when applied to the antibody.

圖9更為詳細地說明了抗體922和導電性誘昇分子942的連結。諸如圖中所顯示具Y型分子結構的抗體922,其結構體上共價鍵結有多個導電性誘昇分子942。此類導電性誘昇分子,諸如圖中所繪示之寡苯基-噻吩及其衍生物,如圖所示之噻吩分子9421,係以苯基9422修飾其末端,並再共價鍵結在抗體922上。有部份導電性誘昇分子,即圖中抗體922之Y型分子結構延伸端上之942A,可將抗體922連結於電極晶片上,且同時亦增進整體電導度。 Figure 9 illustrates the attachment of antibody 922 and conductive derivatory molecule 942 in more detail. An antibody 922 having a Y-type molecular structure as shown in the figure is structurally covalently bonded with a plurality of conductive deriving molecules 942. Such conductively induced molecules, such as the oligophenyl-thiophene and its derivatives depicted in the figures, are shown in the thiophene molecule 9421, modified by phenyl 9422, and covalently bonded thereto. Antibody 922. A portion of the conductive attracting molecule, 942A on the extended end of the Y-type molecular structure of antibody 922, can link antibody 922 to the electrode wafer while also improving overall electrical conductivity.

雖然以上之說明文字,應已利用特定實施例,而完整地描述了本發明,但其各種修改,變化構造及其等效者仍屬可以實施者。因此,以上說明文字及相關圖式,即不應被作為本發明後列專利範圍範疇之限定性解讀。 The present invention has been described in detail with reference to the specific embodiments thereof, and the various modifications, variations, and equivalents thereof are still possible. Therefore, the above description and related drawings are not to be construed as limiting the scope of the scope of the appended claims.

400,700,800‧‧‧感測晶片 400,700,800‧‧‧Sensor wafer

405A,405B,405C,505A,505B,505C 705,805‧‧‧電性傳導環境 405A, 405B, 405C, 505A, 505B, 505C 705, 805‧‧‧Electrically conductive environment

410,510,710,810‧‧‧晶片基材 410,510,710,810‧‧‧ wafer substrate

412,414,512,514,712,714,812,814‧‧‧晶片電極 412,414,512,514,712,714,812,814‧‧‧ wafer electrodes

422,522,722,822,922‧‧‧抗體 422,522,722,822,922‧‧‧antibodies

432,532‧‧‧抗原 432, 532‧‧ ‧ antigen

442,542,742,842,942,942A‧‧‧導電性誘昇分子 442,542,742,842,942,942A‧‧‧ Conductive inducers

圖1顯示一基本電性感測系統之架構。 Figure 1 shows the architecture of a basic electro-sensing system.

圖2A及2B顯示電性感測晶片之兩種可能組構。 2A and 2B show two possible configurations of an electro-sensing wafer.

圖3A及3B說明習知技術電性感測如何不適於利用抗體探針進行抗原之檢測。 Figures 3A and 3B illustrate how conventional electrophysiological measurements are not suitable for antigen detection using antibody probes.

圖4A-4C分別顯示依據本發明感測晶片之一較佳實施例其製備及其對一様本進行感測之情形。 4A-4C respectively illustrate the preparation of a preferred embodiment of a sensing wafer in accordance with the present invention and the sensing of a sample thereof.

圖5A-5C分別顯示依據本發明感測晶片之另一較佳實施例其製備及其對一様本進行感測之情形。 Figures 5A-5C respectively illustrate the preparation of a preferred embodiment of a sensed wafer in accordance with the present invention and the sensing of a sample thereof.

圖6解釋本發明電性感測晶片及方法何以具有實質用途。 Figure 6 illustrates why the electro-sensing wafer and method of the present invention have substantial utility.

圖7顯示依據本發明一實施例感測晶片,其上含有以導電性誘昇分子共價鍵結所固定之抗體,其可提昇整個檢測系統中的電傳導性。 Figure 7 shows a sensing wafer containing an antibody immobilized by covalent bonding of conductively-exposed molecules, which enhances electrical conductivity throughout the detection system, in accordance with an embodiment of the present invention.

圖8顯示依據本發明一實施例感測晶片,其上含有以導電性誘昇分子共價鍵結所固定之抗體,其抗體表面亦導電性誘昇分子修飾,其可提昇整個檢測系統中的電傳導性。 8 shows a sensing wafer according to an embodiment of the present invention, which comprises an antibody immobilized by covalent bonding of a conductive deriving molecule, and the surface of the antibody is also modified by a conductive derivation molecule, which can enhance the entire detection system. Electrical conductivity.

圖9顯示抗體與導電性誘昇分子連結。 Figure 9 shows the attachment of an antibody to a conductive derivatory molecule.

800‧‧‧感測晶片 800‧‧‧Sensor wafer

805‧‧‧電性傳導環境 805‧‧‧Electrically conductive environment

810‧‧‧晶片基材 810‧‧‧ wafer substrate

812,814‧‧‧晶片電極 812,814‧‧‧ wafer electrode

822‧‧‧抗體 822‧‧‧ antibody

842‧‧‧導電性誘昇分子 842‧‧‧ Conductive inducers

Claims (6)

一種可供電性感測一檢測樣本中之抗原之感測器,其包含電性不連接且實質互相分離之二電極;固定於該些電極其中至少一電極之表面上的一層抗體,該抗體相對於該抗原具有具備專一性之結合反應性;與複數個電性誘昇分子,其中每一個電性誘昇分子之一末端為苯基及其衍生物,並經該末端分別共價鍵結於該些抗體上以增進該兩電極間之導電性質。 A sensor capable of supplying a test for detecting an antigen in a sample, comprising: a second electrode electrically disconnected and substantially separated from each other; a layer of antibody immobilized on a surface of at least one of the electrodes, the antibody being relative to The antigen has a specific binding reactivity; and a plurality of electrically induced molecules, wherein one end of each of the electrically induced molecules is a phenyl group and a derivative thereof, and are covalently bonded to the end via the end These antibodies are used to enhance the conductive properties between the two electrodes. 申請專利範圍項1之感測器,其中當出現於與一緩衝液混合之該檢測樣本中之該抗原與該固定有抗體之電極相接觸時,該抗體捕捉該抗原,並因而改變該兩電極之間的電性傳導特性,其中代表該改變的量提供了對該抗原進行電性感測的一個定性及定量指標。 The sensor of claim 1, wherein when the antigen present in the test sample mixed with a buffer is in contact with the antibody-immobilized electrode, the antibody captures the antigen and thus changes the two electrodes The electrical conduction characteristic between, wherein the amount representing the change provides a qualitative and quantitative indicator of electrosensitivity of the antigen. 申請專利範圍項1之感測器,其中該些導電性誘昇分子係以共價鍵結方式鍵結於該些抗體上。 The sensor of claim 1, wherein the conductive attracting molecules are bonded to the antibodies by covalent bonding. 申請專利範圍項1之感測器,其中該層抗體係經由該些導電性誘昇分子而連結至該些電極。 The sensor of claim 1, wherein the layer of anti-system is coupled to the electrodes via the conductive attracting molecules. 申請專利範圍項1之感測器,其中該電性感測係為該兩電極之間利用直流(DC)或交流(AC)所進行之電流量測。 The sensor of claim 1, wherein the electrical sensing system is a current measurement between the two electrodes by direct current (DC) or alternating current (AC). 申請專利範圍項1之感測器,其中該電性感測係為該兩電極之間之電容量測。 The sensor of claim 1, wherein the electrical sensing system is a capacitance measurement between the two electrodes.
TW99100058A 2010-05-18 2010-05-18 Electrosensing antibody-probe detection and measurement sensor having conductivity promotion molecules TWI473997B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW99100058A TWI473997B (en) 2010-05-18 2010-05-18 Electrosensing antibody-probe detection and measurement sensor having conductivity promotion molecules

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW99100058A TWI473997B (en) 2010-05-18 2010-05-18 Electrosensing antibody-probe detection and measurement sensor having conductivity promotion molecules

Publications (2)

Publication Number Publication Date
TW201142288A TW201142288A (en) 2011-12-01
TWI473997B true TWI473997B (en) 2015-02-21

Family

ID=46765028

Family Applications (1)

Application Number Title Priority Date Filing Date
TW99100058A TWI473997B (en) 2010-05-18 2010-05-18 Electrosensing antibody-probe detection and measurement sensor having conductivity promotion molecules

Country Status (1)

Country Link
TW (1) TWI473997B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020076690A1 (en) * 2000-12-14 2002-06-20 The Regents Of The University Of California Impedance measurements for detecting pathogens attached to antibodies
US6478938B1 (en) * 2000-05-24 2002-11-12 Bio Digit Laboratories Corporation Electrochemical membrane strip biosensor

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6478938B1 (en) * 2000-05-24 2002-11-12 Bio Digit Laboratories Corporation Electrochemical membrane strip biosensor
US20020076690A1 (en) * 2000-12-14 2002-06-20 The Regents Of The University Of California Impedance measurements for detecting pathogens attached to antibodies

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Jordan H Wosnick et al., "Molecular photonic and electronic circuitry for ultra-sensitive chemical sensors", Current Opinion in Chemical Biology, Vol. 4, 2000, p. 715-720 *

Also Published As

Publication number Publication date
TW201142288A (en) 2011-12-01

Similar Documents

Publication Publication Date Title
Zamfir et al. Highly sensitive label-free immunosensor for ochratoxin A based on functionalized magnetic nanoparticles and EIS/SPR detection
Radi et al. Label-free impedimetric immunosensor for sensitive detection of ochratoxin A
Limbut et al. A comparative study of capacitive immunosensors based on self-assembled monolayers formed from thiourea, thioctic acid, and 3-mercaptopropionic acid
Yang et al. Detection and discrimination of alpha-fetoprotein with a label-free electrochemical impedance spectroscopy biosensor array based on lectin functionalized carbon nanotubes
Cui et al. An AC electrokinetic impedance immunosensor for rapid detection of tuberculosis
Altintas et al. Gold nanoparticle modified capacitive sensor platform for multiple marker detection
Chebil et al. Electrochemical detection of D-dimer as deep vein thrombosis marker using single-chain D-dimer antibody immobilized on functionalized polypyrrole
US20120037515A1 (en) Impedimetric sensors using dielectric nanoparticles
TWI435873B (en) Electron-conducting molecule for use in antibody probe electrosensing chip
Yu et al. A ratiometric electrochemical sensor for multiplex detection of cancer biomarkers using bismuth as an internal reference and metal sulfide nanoparticles as signal tags
Tarasov et al. Gold-coated graphene field-effect transistors for quantitative analysis of protein–antibody interactions
Rydosz et al. A broadband capacitive sensing method for label-free bacterial LPS detection
Uda et al. Immunosensor development formatting for tungro disease detection using nano-gold antibody particles application
Koç et al. Electrochemical investigation of gold based screen printed electrodes: an application for a seafood toxin detection
Zakaria et al. An impedimetric micro-immunosensing assay to detect Alzheimer's disease biomarker: Aβ40
Selimoğlu et al. Silver nanoparticle doped graphene-based impedimetric biosensor towards sensitive detection of procalcitonin
Bothara et al. Nanomonitors: electrical immunoassays for protein biomarker profiling
US20070072286A1 (en) Label-free detection of biomolecules
Pimenta et al. Impedimetric immunosensor for dengue diagnosis using graphite screen-printed electrodes coated with poly (4-aminophenylacetic acid)
Tran Nhu et al. Comparison of faradaic and non-faradaic impedance biosensors using 2-electrode and 3-electrode configurations for the determination of bovine serum albumin (BSA)
Deng et al. A novel potentiometric immunoassay for carcinoma antigen 15-3 by coupling enzymatic biocatalytic precipitation with a nanogold labelling strategy
TWI473997B (en) Electrosensing antibody-probe detection and measurement sensor having conductivity promotion molecules
Jin et al. Disposable impedance-based immunosensor array with direct-laser writing platform
Zaccari et al. Label-free electrochemical biosensors for clinical diagnostic
Ortiz Ortega et al. Characterization techniques for electrochemical analysis

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees